BETA.NS · Beta Drugs Limited
India · RS rating 30 · As of 2026-10-14
| Price | 1,699.50 INR |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 3 / 6 / 60 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 42 / 36 / 45 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +65.5% |
| Sales growth Q/Q | +33.6% |
| Distance from 52-week high | +36.3% |
| Market cap (USD) | $207.8M |